Loading…
← CockpitCompetitor Analysis › 1833.HK Ping An Healthcare and Technology Company LimitedOpen in the cockpit ↗

Ping An Healthcare and Technology Company Limited1833.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Health Care›Medical/Nursing Services

Ping An-backed online healthcare platform offering telemedicine consultations, health management and online pharmacy services.

≈ China's Teladoc, backed by an insurance giantMomentum laggard 18
Mkt cap
$1.36B
US dollars, full cap
Free float
41%
of shares outstanding
$/day
$5.61M
20-day average traded
Fwd P/E
33.5×
forward earnings
ROIC−WACC
-6.8 pp
WACC 11.8%
Hurdle
+9 pp
Req g minus delivered
Next earnings
118 days
16 Mar 2027
Close · HKDHK$5.11
1D-0.5%
1W-11.4%
1M-12.6%
3M-28.3%
6M-47.3%
YTD-63.7%
1Y-62.3%
ATR %4.2%
52w lowhigh72.8% off high

What Ping An Healthcare and Technology does

Ping An-backed online healthcare platform offering telemedicine consultations, health management and online pharmacy services.

Much of its revenue has come from the Ping An group's own customers, through family-doctor memberships bundled with insurance and employee health plans, plus medicine sales on its online pharmacy. Ping An Insurance is the controlling shareholder, so group sales channels matter.

In one line: China's Teladoc, backed by an insurance giant.

Products and services

  • Online medical consultations
  • Online pharmacy/health mall
  • Corporate/enterprise health management
  • Health insurance-linked services

Customers

  • Consumers
  • Corporate clients (employee health benefits)
  • Ping An insurance policyholders

Where it sits in the supply chain

  • Health Care
  • Digital health
  • Telemedicine & online pharmacy

What could go right

  • China digital-health adoption growth

What could go wrong

  • Path-to-profitability execution risk
  • Regulatory scrutiny of online pharmacy/telemedicine

Moat: narrow (brand, data, distribution). Ping An ecosystem integration and an established telemedicine user base differentiate it, though profitability has been elusive.

Headquarters: Shanghai, China · Founded: 2014 · Employees: 1,668

Named competitors

Ping An Healthcare and Technology at a glance

Size Ping An Healthcare and Technology (1833.HK) is a Hong Kong Health Care company (Medical/Nursing Services) with a market value of $1.36B, the 498th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$5.11 on 18 Nov 2026.

Performance Over six months the shares fell 47.3%, against +17.1% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue grew 7.9% over the last twelve months (peer median +6.8%); the operating margin is 3.3% (peer median 6.2%).

Valuation It trades at 33.5× forward earnings against a peer median of 23.7× (7th most expensive of 16).

Price implies For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is -5%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 6.8 points below its cost of capital (11.8% WACC).

Next results Next results expected around 16 Mar 2027 (exchange calendar; dates can move).

Relative performance

507510012521 May 202621 Aug 202618 Nov 2026Peer median 1171833.HK 53
Six months, rebased to 100: Ping An Healthcare and Technology against the median of its 20 peers (local-currency closes).

Ping An Healthcare and Technology financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$6.08BHK$5.93BHK$5.21BHK$5.16BHK$7.22B
Revenue growth—+14%+1%-28%—
Gross profitHK$2.11BHK$1.92BHK$1.65BHK$1.67BHK$1.94B
EBITDAHK$284MHK$284M-HK$80.1M-HK$714M-HK$1.17B
Net incomeHK$519MHK$412MHK$88.3M-HK$356M-HK$740M
Free cash flowHK$386MHK$436MHK$400M-HK$1.48M-HK$899M
Capital expenditureHK$47.8MHK$43.3MHK$37.1MHK$47.5MHK$40.0M
Total debtn/aHK$44.3MHK$47.9MHK$103MHK$198M

Quarterly statements and history in the cockpit →

Ping An Healthcare and Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%0%+20%LMRICLARIUSPH4544DIATDOCPNTGOPKMETROPOLISAGLWGSNUTXAMBEASNDAGDRXPSNLVIJAYA300244EMEIS6883151833.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Ping An Healthcare and Technology is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×60×LMRICLARIUSPH4544DIAPNTGMETROPOLISAGLWGSNUTXAMBEAGDRXVIJAYA3002446883151833.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Ping An Healthcare and Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+100%+200%0%100%200%CLARIUSPH4544TDOCMETROPOLISNUTX1833.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Ping An Healthcare and Technology is the large dot.

Ping An Healthcare and Technology competitors and peer comparison

Head to head with its named competitors (1833.HK vs 6618.HK vs 0241.HK vs TDOC)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Ping An Healthcare and Technology 1833.HK$1.36B-47%+8%3%33.5×3.5%
Jd Health 6618.HK$13.3B-15%+26%6%14.7×-0.9%
Ali Health 0241.HK$5.51B-31%+14%5%18.1×20.2%
Teladoc Health TDOC$1.47B+24%-2%-5%n/a-6.4%

How Ping An Healthcare and Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Ping An Healthcare and Technology against its 20 peers (data as of 18 Nov 2026)
Measure1833.HKPeer medianRank in peer set
1-month return-12.6%-0.3%5th lowest of 21
6-month return-47.3%+17.1%lowest of 21
Distance from 52-week high-72.8%-22.2%lowest of 21
Revenue growth (TTM)+7.9%+6.8%10th highest of 21
Operating margin3.3%6.2%10th lowest of 21
Forward P/E33.5×23.7×7th most expensive of 16
Growth the price implies (Req g, 7 yrs)3.5%8.5%5th least demanding of 15
Growth delivered (Del g)-5.1%+9.5%lowest of 15
Hurdle (Req g minus delivered)+8.6 pp+1.3 pp4th most demanding of 15
ROIC minus cost of capital-6.8 pp-3.1 pp7th lowest of 20
Net debt / EBITDA-29.2×2.8×least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Ping An Healthcare and Technology 1833.HKHong Kong$1.36B-47%+8%3%33.5×3.5%-5.1%
Lumexa Imaging LMRIUnited States$1.35B+89%+8%2%16.0×n/an/a
Clariane CLARI.PAFrance$1.32B-20%+1%6%8.2×6.8%+6.5%
U.S. Physical Therapy USPHUnited States$1.42B+53%+10%10%29.4×18.8%+13.0%
H.U.Group 4544.TJapan$1.44B+24%+1%3%39.9×9.7%+2.1%
Diagnostyka DIA.WAPoland$1.28B-6%+19%15%19.5×7.3%+18.9%
Teladoc Health TDOCUnited States$1.47B+24%-2%-5%n/a-6.4%+18.3%
Pennant PNTGUnited States$1.26B+1%+39%6%23.7×20.7%+19.4%
OPKO Health OPKUnited States$1.25B+37%-22%-29%n/an/an/a
Metropolis Healthcare METROPOLIS.NSIndia$1.25B+11%+20%18%44.5×32.4%+10.5%
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
Nutex Health NUTXUnited States$1.19B+42%-19%39%6.5×-18.0%+253.5%
Ambea AMBEA.STSweden$1.59B+28%+11%9%15.2×1.1%+7.7%
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
GoodRx GDRXUnited States$1.15B+33%-2%12%10.6×6.3%+7.7%
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
Vijaya Diagnostic Centre VIJAYA.NSIndia$1.69B+18%+24%32%63.0×40.4%+16.7%
Dian Diagnostics 300244.SZChina$1.70B+1%-5%9%21.8×0.3%-1.1%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%
Novogene 688315.SSChina$1.01B+13%+6%7%44.8×13.9%+8.2%

Questions

Who are Ping An Healthcare and Technology's main competitors?
Named competitors: JD Health (6618.HK), Alibaba Health (0241.HK), Teladoc Health (TDOC). The cockpit's measured peer set (industry) also includes Lumexa Imaging (LMRI), Clariane (CLARI.PA), U.S. Physical Therapy (USPH), H.U.Group (4544.T), Diagnostyka (DIA.WA), Teladoc Health (TDOC).
Is Ping An Healthcare and Technology expensive compared with its peers?
On forward p/e it trades at 33.5× against a peer median of 23.7×, 7th most expensive of 16 in its peer set. For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is -5%, so the hurdle is +9 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Ping An Healthcare and Technology stock performed?
Over six months to 18 Nov 2026 the shares returned -47.3% against +17.1% for the median peer; over one year -62.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.